For in vitro diagnostic use. Others Elecsys Rubella IgG IVD Elecsys® Rubella IgG CPS_000508 04618793190 Rubella IgG Elecsys cobas e 100 Elecsys Rubella IgG 04015630921423 Reagents, kits 100 tests cobas e 411/601/602 true 04618793160 Rubella IgG Elecsys cobas e 100 Elecsys Rubella IgG 04015630939251 Reagents, kits 100 tests cobas e 411/601/602 true 07027770190 Rubella IgG Elecsys E2G 300 Elecsys Rubella IgG 04015630940240 Reagents, kits 300 tests cobas e 402/801 true 04618793500 Elecsys Rubella IgG en 12 FF000000069CAE0E FF00000000111A0E 04618793190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of IgG antibodies to Rubella virus in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 04618793501 Elecsys Rubella IgG en 9 FF0000000741D00E FF0000000004270E 04618793160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThis assay is for the in vitro quantitative determination of IgG antibodies to rubella virus in human serum and heparin, EDTA and citrate plasma. This assay may be used as an aid in the assessment of immune status to rubella in individuals including women of childbearing age.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027770500 Elecsys Rubella IgG en 7 FF0000000693300E FF0000000497740E 07027770190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of IgG antibodies to Rubella virus in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027770501 Elecsys Rubella IgG en 3 FF0000000516200E FF00000001F3080E 07027770190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use This assay is for the in vitro quantitative determination of IgG antibodies to rubella virus in human serum and heparin, EDTA and citrate plasma. This assay may be used as an aid in the assessment of immune status to rubella in individuals including women of childbearing age.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027770501 Elecsys Rubella IgG en 4 FF00000005D1B70E FF00000001DD8E0E 07027770190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use This assay is for the in vitro quantitative determination of IgG antibodies to rubella virus in human serum and heparin, EDTA and citrate plasma. This assay may be used as an aid in the assessment of immune status to rubella in individuals including women of childbearing age.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027770501 Elecsys Rubella IgG en 5 FF0000000741D50E FF00000005D1B70E 07027770190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use This assay is for the in vitro quantitative determination of IgG antibodies to rubella virus in human serum and heparin, EDTA and citrate plasma. This assay may be used as an aid in the assessment of immune status to rubella in individuals including women of childbearing age.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en